Viveve Medical (VIVE) Now Covered by Northland Securities
Northland Securities initiated coverage on shares of Viveve Medical (NASDAQ:VIVE) in a research report report published on Friday, MarketBeat.com reports. The brokerage issued an outperform rating and a $8.00 price objective on the stock.
Several other research analysts also recently commented on the stock. ValuEngine downgraded shares of Viveve Medical from a sell rating to a strong sell rating in a research note on Friday, December 1st. Mizuho started coverage on shares of Viveve Medical in a research note on Thursday, November 16th. They set a buy rating and a $10.00 price target on the stock. Finally, Cowen set a $11.00 price target on shares of Viveve Medical and gave the stock a buy rating in a research note on Monday, October 23rd. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $10.00.
Shares of Viveve Medical (NASDAQ:VIVE) traded down $0.01 on Friday, reaching $4.96. 123,600 shares of the company were exchanged, compared to its average volume of 134,600. The stock has a market capitalization of $96.36, a P/E ratio of -2.30 and a beta of -0.66. The company has a debt-to-equity ratio of 2.72, a current ratio of 3.89 and a quick ratio of 3.63. Viveve Medical has a 1-year low of $3.75 and a 1-year high of $11.16.
Several institutional investors have recently modified their holdings of the company. Neuberger Berman Group LLC bought a new position in shares of Viveve Medical in the third quarter worth approximately $419,000. Granahan Investment Management Inc. MA grew its holdings in shares of Viveve Medical by 32.6% in the third quarter. Granahan Investment Management Inc. MA now owns 102,147 shares of the company’s stock worth $535,000 after purchasing an additional 25,097 shares during the last quarter. RTW Investments LP grew its holdings in shares of Viveve Medical by 18.8% in the third quarter. RTW Investments LP now owns 1,473,028 shares of the company’s stock worth $7,719,000 after purchasing an additional 233,585 shares during the last quarter. ING Groep NV grew its holdings in shares of Viveve Medical by 93.7% in the third quarter. ING Groep NV now owns 325,000 shares of the company’s stock worth $1,703,000 after purchasing an additional 157,200 shares during the last quarter. Finally, California State Teachers Retirement System bought a new position in shares of Viveve Medical in the second quarter worth approximately $190,000. Hedge funds and other institutional investors own 66.90% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Viveve Medical (VIVE) Now Covered by Northland Securities” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally copied and republished in violation of United States and international copyright law. The legal version of this article can be accessed at https://www.thecerbatgem.com/2018/01/08/viveve-medical-vive-now-covered-by-northland-securities.html.
About Viveve Medical
Viveve Medical, Inc designs, develops, manufactures and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System (a radio frequency (RF), generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories.
Receive News & Stock Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related stocks with our FREE daily email newsletter.